CHRODIS PLUS Croatian pilot – Baseline analysis of indicators

Slides:

Advertisements

Similar presentations

Streatham & Clapham Health Renal Outreach Clinic

Advertisements

Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.

Flow diagram showing study population of Chinese patients with type 2 diabetes mellitus and reasons for exclusion Yang X et al. CMAJ 2008;179:

Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.

Association of 1,5-Anhydroglucitol with Diabetes and Microvascular

Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.

Lancet : doi: /S (08)60104-X Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from.

DIABETES With All My Heart Presented by: Regina Weitzman, MD.

The use of hospital pharmacy profiles to identify patients with metabolic syndrome and their history of nutrition intervention from a registered dietitian.

Kotseva K, et al. Eur J Cardiovasc Prev Rehabil 2009 Mar 12 [Epub]

Changes that Work The Healthy Worksite Initiative HWI Outcomes Conference Kathy Reims, MD September 23, 2009.

Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.

EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CARE Authors Institutions Authors: Silvia Martínez-Valverde MSc 1, Hortensia.

© 2003, Wellsource Inc. Effect of Ketogenic Diet on Lipid Levels (shown is LDL-C) In this group of 141 children followed for 6 months, a ketogenic diet.

Comprehensive Diabetes Care. Comprehensive Diabetes Care: HbA1c Testing (Commercial) Source: National Committee for Quality Assurance, The State of Health.

The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.

Diabetes and High Blood Pressure Are Like Twins. Ignoring Your High Blood Pressure.

L-Arginine Clinical Trial Results of Study 18% increase in HDL 18% increase in HDL 40% decrease in triglycerides 40% decrease in triglycerides 8% glucose.

Lowering Your Cholesterol University Medical Center Community Education Program.

PICK A CARD When the picture you hold in your hand is displayed you will be asked a question Ready set go…….

The Effects of Brisk Walking on Biochemical Risk Factors and Functional Capacity in Healthy, Sedentary 50 to 65 Year Old Patients of Primary Care M.Tully.

Value of Pharmacy Services January 31 st (A), 2011 J. Hirsch, Ph.D. SSPPS – 207 Introduction to Health Care Systems and Policy.

Electronic patient record since SDC Quality of Care Data 2009 – 2011 for Type 1 Diabetes NCQA indicatorGoal HbA1c > 9,0 %≤ 15%

Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.

6-year vision loss in patients newly diagnosed with clinical type 2 diabetes. What can the patients expect? Niels de Fine Olivarius Volkert Siersma Gitte.

Connecting World Class Science to Consumer Health Founder Teresa O’KeefeCEO Tim Davenport.

GO! Diabetes Train the Trainer Program. Practice Performance and Improvement.

Metabolic Comorbidities of Young Children

From ESH 2016 | LB 3: Davide Agnoletti, MD

Showcasing work by Jonnageddala, Liaw, Ray, Kumar, Chang, and Dai on

The Practice Education and Enhancement Project in Diabetes Mellitus

Raw data Log-transformed data Male age log age Female age log age

Copyright © 2012 American Medical Association. All rights reserved.

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.

Arterioscler Thromb Vasc Biol

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Cholesterol and blood pressure values at baseline and after 15 days of dark-chocolate and white-chocolate consumption Characteristic Dark chocolate before.

Heart Healthy Workouts

Sodium-glucose co-transporter 2 (SGLT2) inhibitors work by blocking the reabsorption of filtered glucose in the kidneys. This leads to glucosuria and improved.

Volume 375, Issue 9709, Pages (January 2010)

How to Teach it?.

Description of studies for pooled analyses

Fort Atkinson School District Wellness Program

The Diabetes Cross-Disciplinary Index (DXDI).

The prevalence of Recurrent Stroke and TIA and the related factors

Ongoing statin therapy at hospitalization for acute myocardial infarction. Learnings for general practitioners. Ghena Shabana Specialist in Family Medicine.

Baseline Characteristics, Blood Pressures, and Laboratory Values

Baseline Characteristics of the Subjects*

DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.

Change in (A) total cholesterol; (B) LDL-cholesterol; (C) HDL-cholesterol and (D) triglycerides over 5 years in response to 12-week intensive lifestyle.

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors Barry M. Brenner, Joann Zagrobelny

Lars E. Laugsand et al. BTS 2016;j.jacbts

Change in (A) systolic blood pressure and (B) diastolic blood pressure over 5 years in response to 12-week intensive lifestyle intervention in a real-world.

CHRODIS + Croatian pilot from the MoH perspective

Key performance indicators

CROATIAN HEALTH INSURANCE FUND

The ACCORD Study Group. NEJM 2010; Epub March 14

Relationship between selected metabolic parameters and the primary composite end point. Relationship between selected metabolic parameters and the primary.

Percentage of patients with type 2 diabetes with A1C < 7% (n = 248), blood pressure > 130/80 mmHg (n = 248), and LDL cholesterol < 100 mg/dl (n = 207)

Tamara Poljičanin, MD, PhD Croatian Institute of Public Health

Sustainability and scalability Croatian Institute of Public Health

Two-year changes in albumin-to-creatinine ratio across microalbuminuria at baseline. Two-year changes in albumin-to-creatinine ratio across microalbuminuria.

Atrasentan reduces albuminuria in diabetic apoE KO mice.

Mean adjusted levels in each group for the following cardiometabolic risk factors at 3 and 12 months postpartum: (A) systolic blood pressure, (B) diastolic.

2 years ago Test Body: Height Weight BMI Girth Eye Strength:

(D) Systolic blood pressure (BP) values at baseline and after treatment with anagliptin in 20 participants at 12 and 24 weeks. . (D) Systolic blood pressure.

Effects of placebo or carvedilol CR on 24-hour mean systolic blood pressure and diastolic blood pressure obtained by ambulatory monitoring in hypertensive.

© The Author(s) Published by Science and Education Publishing.

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

Presentation transcript:

CHRODIS PLUS Croatian pilot – Baseline analysis of indicators Domina Vusio Croatian Institute of Public Health Zagreb, 26th-27th March 2019

Measures: panel level Share of persons with regularly completed diabetes panel Availability of accurate indicators Trend of chosen diabetes QI within diabetes panel - including glycaemic regulation, systolic and diastolic blood pressure, total, HDL and LDL cholesterol, triglycerides and albumin/ creatinine ratio, fundoscopy and feet examination in previous 12 months. Values for 2015, 2016 and 2017 will be compared. Changes in diabetes panel that enable higher level of agreement (or complete) with MDS and monitoring of health status history

Measures: GP level Share of persons with completed diabetes panel among diabetic patients in care Availability of accurate indicators Chosen diabetes QI within diabetes panel - including glycaemic regulation, systolic and diastolic blood pressure, total, HDL and LDL cholesterol, triglycerides and albumin/ creatinine ratio, fundoscopy and feet examination in previous 12 months. Improving awareness of GPs on and patients of potential benefits from MDS – interview results Change in previously mentioned measures before and after the intervention – measures taken before the start of our pilot period will be compared with measures taken six months after the end of our pilot period in order to evaluate the result of our intervention (taking into account possible lag effect)

Panel level: example

Panel level: example

GP level: example

GP level: example

Thank you for your attention!